Inactive Instrument
ImmunoGen, Inc. Share Price
Stocks
IMGN
US45253H1014
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Stacy Coen
PRN | Corporate Officer/Principal | 55 | 03/06/2020 |
Theresa Wingrove
CTO | Chief Tech/Sci/R&D Officer | 68 | 24/01/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/02/24 | Issuer sale | Director | 3,54,013 | 0.1267% | ||
| 12/02/24 | Issuer sale | General Counsel | 4,23,825 | 0.1517% | ||
| 12/02/24 | Issuer sale | CHIEF EXECUTIVE OFFICER; Director | 50,71,495 | 1.8154% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +6.73% | - | - | 835.91Cr | |
| +4.16% | +3.42% | +49.37% | +94.17% | 7.43TCr | |
| +1.06% | -3.23% | +20.77% | +75.58% | 5.7TCr | |
| +2.47% | +0.82% | +5.67% | +37.25% | 4.83TCr | |
| +0.50% | +2.94% | +344.62% | +722.17% | 4.45TCr | |
| +3.05% | -1.80% | +28.78% | +34.51% | 4.38TCr | |
| +1.00% | -1.46% | +5.17% | +111.90% | 4.11TCr | |
| -0.54% | +2.41% | +9.31% | +58.85% | 3.11TCr | |
| +4.51% | +8.22% | +37.86% | +32.49% | 2.9TCr | |
| +0.76% | -1.45% | -7.44% | -11.12% | 2.45TCr | |
| Average | +1.80% | -0.15% | +54.90% | +128.42% | 4.37TCr | |
| Weighted average by Cap. | +2.10% | -0.46% | +58.80% | +136.85% |
Employees
277
